SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001070081-23-000040
Filing Date
2023-07-17
Accepted
2023-07-17 16:46:55
Documents
13
Period of Report
2023-07-13
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K tmb-20230713x8k.htm   iXBRL 8-K 49833
2 EX-10.1 tmb-20230713xex10d1.htm EX-10.1 210794
  Complete submission text file 0001070081-23-000040.txt   422533

Data Files

Seq Description Document Type Size
3 EX-101.SCH tmb-20230713.xsd EX-101.SCH 3124
4 EX-101.LAB tmb-20230713_lab.xml EX-101.LAB 15266
5 EX-101.PRE tmb-20230713_pre.xml EX-101.PRE 9657
7 EXTRACTED XBRL INSTANCE DOCUMENT tmb-20230713x8k_htm.xml XML 4675
Mailing Address 100 CORPORATE COURT SOUTH PLAINFIELD NJ 07080-2449
Business Address 100 CORPORATE COURT SOUTH PLAINFIELD NJ 07080-2449 9082227000
PTC THERAPEUTICS, INC. (Filer) CIK: 0001070081 (see all company filings)

IRS No.: 043416587 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35969 | Film No.: 231092058
SIC: 2834 Pharmaceutical Preparations